The global pharma industry experienced a 31% drop in new job postings in Q3 2023 compared with the previous quarter, with the highest share accounted for by CSL with 4,283 job postings according to GlobalData’s analysis of pharma company job postings. GlobalData’s Pharma: Hiring Trends & Signals Q3 2023 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Management Occupations jobs accounted for a 19% share of the global pharma industry’s new job postings in Q3 2023, down 44% over the prior quarter.
Management Occupations drive pharma industry hiring activity
Management Occupations, with a share of 19%, was the occupation with the greatest hiring activity in the global pharma industry in Q3 2023, ahead of Healthcare Practitioners and Technical Occupations with a 9% share of job postings.
See Also:
The other prominent roles include Life, Physical, and Social Science Occupations with an 8% share in Q3 2023, Computer and Mathematical Occupations with a 45% share and Business and Financial Operations Occupations with a 5% share of new job postings.
Top five companies in pharma industry accounted for 29% of hiring activity
The top five companies, in terms of number of new job postings tracked by GlobalData, accounted for a combined 29% share of the overall hiring activity in the global pharma industry in Q3 2023.
CSL posted 4,283 jobs in Q3 2023 and registered a growth of 37% over the previous quarter, followed by AstraZeneca with 4,070 jobs and a 7% decline. Novo Nordisk with 3,475 jobs and Merck with 3,346 jobs, recorded a 26% decline and a 24% drop, respectively, while Grifols recorded a 62% rise with 3,311 job postings during Q3 2023.
Hiring activity was driven by North America with a 49% share of total new job postings, Q3 2023
North America held the leading share of the new job postings in the global pharma industry with a 49% share, a 3% higher over Q2 2023. Europe stood next with 26%, registering a 33% decline over the previous quarter.
Asia-Pacific with a 20% share marked a 38% drop over Q2 2023. The South & Central America and Middle East & Africa accounted for shares of 30% and 26% respectively.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q3 2023, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.